US$ 22.08
glp-1 obesity drug news oct 21 2025 Market 2024 was a record year
Description
Often, these outlets sell low-cost copycats of obesity medications compounded versions made by pharmacies that measure and dissolve drug ingredients, creating their own injectable product

Peak Wellness does not appear to offer specific protocols for medication discontinuation or maintenance planning

[DOI] [PMC free article] [PubMed] [Google Scholar] 19.Malhotra A, et al
They can also be more expensive than pills

The prices should soon come down, though, either because governments negotiate them down or because of competition

Research: The SCALE trial assessed weight loss outcomes in people with obesity receiving a once-daily injection of liraglutide over 14 months (56 weeks)
